ARCA Biopharma Inc (NASDAQ:ABIO)
| 2.03 Delayed Data As of Mar 24 |  0.00 / 0.00%Today’s Change | 1.76 Today|||52-Week Range 2.70 | -14.35% Year-to-Date |
Latest ABIO News | Press Releases
No recent news for ARCA Biopharma Inc.
Today’s Trading
| Previous close | 2.03 |
| Today’s open | 2.03 |
| Day’s range | 2.03 - 2.03 |
| Volume | 200 |
| Average volume (3 months) | 35,122 |
| Market cap | $29.4M |
Data as of 3:56pm ET, 03/24/2023
Growth & Valuation
| Earnings growth (last year) | +50.44% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +30.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.71 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Avricore Health Inc | 0.00 | 0.00% |
| ERYPErytech Pharma SA | -0.06 | -6.03% |
| ENTXEntera Bio Ltd | -0.03 | -2.83% |
| ---- |
Data as of 3:59pm ET, 03/24/2023
Financials
| Last reporting date | November 3, 2021 |
| EPS forecast (this quarter) | -$2.30 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$9.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Westminster, Colorado |
Forecasts
